Teladoc Health, Inc.
TDOCUS売上高
$2.5B
百万USD
営業利益
$-263M
百万USD
純利益
$-200M
百万USD
ROE
-14.5%
最新FY
EPS
$-1.14
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | - | $-200M | - |
| FY2021 | Q2 | - | $-134M | - |
| FY2021 | Q3 | - | $-84M | - |
| FY2021 | FY | - | $-429M | $-2.73 |
| FY2022 | Q1 | - | $-6.7B | $-41.58 |
| FY2022 | Q2 | $592M | $-3.1B | $-19.22 |
| FY2022 | Q3 | $611M | $-73M | $-0.45 |
| FY2022 | FY | $2.4B | $-13.7B | $-84.60 |
| FY2023 | Q1 | $629M | $-69M | $-0.42 |
| FY2023 | Q2 | $652M | $-65M | $-0.40 |
| FY2023 | Q3 | $660M | $-57M | $-0.35 |
| FY2023 | FY | $2.6B | $-220M | $-1.34 |
| FY2024 | Q1 | $646M | $-82M | $-0.49 |
| FY2024 | Q2 | $642M | $-838M | $-4.92 |
| FY2024 | Q3 | $641M | $-33M | $-0.19 |
| FY2024 | FY | $2.6B | $-1.0B | $-5.87 |
| FY2025 | Q1 | $629M | $-93M | $-0.53 |
| FY2025 | Q2 | $632M | $-33M | $-0.19 |
| FY2025 | Q3 | $626M | $-50M | $-0.28 |
| FY2025 | FY | $2.5B | $-200M | $-1.14 |
| FY2026 | Q1 | $614M | $-64M | $-0.36 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | - | - | - | $2.4B | $2.6B | $2.6B | $2.5B |
| 営業利益 | $-63M | $-75M | $-71M | $-80M | $-506M | $-266M | $-13.7B | $-249M | $-1.0B | $-263M |
| 純利益 | $-74M | $-107M | $-97M | $-99M | $-485M | $-429M | $-13.7B | $-220M | $-1.0B | $-200M |
| 総資産 | $304M | $824M | $1.5B | $1.6B | $17.8B | $17.7B | $4.3B | $4.4B | $3.5B | $2.9B |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $231M | $559M | $1.0B | $1.0B | $15.9B | $16.0B | $2.3B | $2.3B | $1.5B | $1.4B |
| 営業CF | - | $-34M | $-5M | $30M | $-54M | $194M | $189M | $350M | $294M | $294M |
| EPS | - | - | - | - | - | $-2.73 | $-84.60 | $-1.34 | $-5.87 | $-1.14 |
| BPS | $4.26 | $9.05 | $14.32 | $13.89 | $104.02 | $100.08 | $14.19 | $13.93 | $8.59 | $7.77 |
| ROE | -32.1% | -19.1% | -9.6% | -9.7% | -3.1% | -2.7% | -591.9% | -9.5% | -67.1% | -14.5% |